A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders3rd edit. American Psychiatric Assoc., Washington, D.C. 1980, (DSM-III)1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders3rd edit. American Psychiatric Assoc., WashingtonD.C. 1980, (DSM-III)
   Google Scholar
• Amin M. M., Ananth J. V., Carranza J., Coleman B. S., Darcourt G., Farkas T., Goldstein B., Lapierre Y. D., Paykel E., Wakelin J. S. Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin. Neuropharmncol. 1984; 7(Suppl. 1)580–5812. Amin M. M., Ananth J. V., Carranza J., Coleman B. S., Darcourt G., Farkas T., Goldstein B., Lapierre Y. D., Paykel E., Wakelin J. S. Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin. Neuropharmncol. 1984; 7(Suppl. 1)580–581
   Google Scholar
• Benfield P., Ward A. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986; 32: 313–3343. Benfield P., Ward A. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986; 32: 313–334
   PubMed Web of Science ®Google Scholar
• Coleman B. S., Block B. A. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. Prvg. Neuro-Psychvpharmucol. Biol. Psychiatry 1982; 6: 475–4784. Coleman B. S., Block B. A. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. Prvg. Neuro-Psychvpharmucol. Biol. Psychiatry 1982; 6: 475–478
   PubMed Web of Science ®Google Scholar
• Curran H. V., Lader M. The psychopharmacological effects of repeated doses of fluvoxamine. mianserin and placebo in healthy human subjects. Euc J. Clin. Pharmacol. 1986; 29: 601–6075. Curran H. V., Lader M. The psychopharmacological effects of repeated doses of fluvoxamine. mianserin and placebo in healthy human subjects. Euc J. Clin. Pharmacol. 1986; 29: 601–607
   PubMed Web of Science ®Google Scholar
• Garattini S., Mennini T., Samanin R. Reduction of food intake by manipulation of central serotonin. Br. J. Psychiutcv 1989; 155(Suppl. 8)41–516. Garattini S., Mennini T., Samanin R. Reduction of food intake by manipulation of central serotonin. Br. J. Psychiutcv 1989; 155(Suppl. 8)41–51
   Google Scholar
• Gonella G., Baignoli G., Ecari U. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curc Med. Res. Opin. 1990; 12: 177–1847. Gonella G., Baignoli G., Ecari U. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curc Med. Res. Opin. 1990; 12: 177–184
   PubMed Web of Science ®Google Scholar
• ECDEU Assessment Manual for Psychopharmacology, W. Guy. DHEW Publication No. (ADM) 76–338, National Institute of Mental Health, Rockville, MD 1976; 218–2228. ECDEU Assessment Manual for Psychopharmacology, W. Guy. DHEW Publication No. (ADM) 76–338, National Institute of Mental Health, RockvilleMD 1976; 218–222
   Google Scholar
• Hindmarch I. A 1,4 benzodiazepine, temazepam (K3917), its effect on some psychological parameters of sleep and behaviour. Arzneim. Fvrsch. 1975; 25: 1836–18399. Hindmarch I. A 1,4 benzodiazepine, temazepam (K3917), its effect on some psychological parameters of sleep and behaviour. Arzneim. Fvrsch. 1975; 25: 1836–1839
   PubMed Web of Science ®Google Scholar
• Inman W. H. W. Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancer. 1988; 2: 90–4210. Inman W. H. W. Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancer. 1988; 2: 90–42
   PubMed Web of Science ®Google Scholar
• Lapierre Y. D., Browne M., Horn E., Oyewumi L. K., Sarantidis D., Roberts N., Badoe K., Tessier P. Treatment of major affective disorder with fluvoxamine. J. Clin. Psychiatrv. 1987; 48: 65–6811. Lapierre Y. D., Browne M., Horn E., Oyewumi L. K., Sarantidis D., Roberts N., Badoe K., Tessier P. Treatment of major affective disorder with fluvoxamine. J. Clin. Psychiatrv. 1987; 48: 65–68
   PubMed Web of Science ®Google Scholar
• Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiuwy 1979; 134: 382–38912. Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiuwy 1979; 134: 382–389
   PubMed Web of Science ®Google Scholar
• Moon C. A. L., Jesinger D. K. Fluvoxamine versus mianserin: psychomotor performance in depressed patients. J. Psychopharmacol. 1989; 3: 93P13. Moon C. A. L., Jesinger D. K. Fluvoxamine versus mianserin: psychomotor performance in depressed patients. J. Psychopharmacol. 1989; 3: 93P
   Google Scholar
• Mullin J., Pandita-Gunawardena V. R., Whitehead A. M. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br. J. Clin.Pruct. 1988; 42: 51–5514. Mullin J., Pandita-Gunawardena V. R., Whitehead A. M. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br. J. Clin.Pruct. 1988; 42: 51–55
   PubMedGoogle Scholar
• Stone B. M. Pencil and paper tests — sensitivity to psychotropic drugs. Br. J. Clin. Pharmacol. 1984; 18(Suppl. I)15S–20S15. Stone B. M. Pencil and paper tests — sensitivity to psychotropic drugs. Br. J. Clin. Pharmacol. 1984; 18(Suppl. I)15S–20S
   PubMedGoogle Scholar
• Wurtmann J. J. Carbohydrate craving, mood changes, and obesity. J. Clin. Psychiatry 1988; 49(Suppl. 8)37–3916. Wurtmann J. J. Carbohydrate craving, mood changes, and obesity. J. Clin. Psychiatry 1988; 49(Suppl. 8)37–39
   Google Scholar